FEBS 2019 P-35-166. Antitumor activity of organic selenium compounds in hepatic cancers

I invite you to the discussion about an organic selenium compound, called selol during 44th FEBS Congress. My study aimed to analyze the potential antitumor effect of selol in human hepatocellular carcinoma-derived cell lines and another in vitro models of human cancers.